The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP)

Diane Paskiet; Dennis Jenke; Douglas Ball; Christopher Houston; Daniel L. Norwood; Ingrid Markovic

doi:10.5731/pdajpst.2013.00936

Review ArticlePQRI Special Section

The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP)

Diane Paskiet, Dennis Jenke, Douglas Ball, Christopher Houston, Daniel L. Norwood and Ingrid Markovic

PDA Journal of Pharmaceutical Science and Technology September 2013, 67 (5) 430-447; DOI: https://doi.org/10.5731/pdajpst.2013.00936

Diane Paskiet

1West Pharmaceutical Services, Exton PA, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: diane.paskiet@westpharma.com

Dennis Jenke

2Baxter Healthcare Corporation, Round Lake, IL, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Douglas Ball

3Pfizer, Inc., Groton, CT, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christopher Houston

4Bausch & Lomb, Rochester, NY, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel L. Norwood

5Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ingrid Markovic

6United States Food and Drug Administration, Washington, DC, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
References
Info & Metrics
PDF

Article Information

vol. 67 no. 5 430-447

DOI

https://doi.org/10.5731/pdajpst.2013.00936

PubMed

24084659

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online October 1, 2013.

Author Information

Diane Paskiet1,*,
Dennis Jenke2,
Douglas Ball3,
Christopher Houston4,
Daniel L. Norwood5 and
Ingrid Markovic6

¹West Pharmaceutical Services, Exton PA, USA;
²Baxter Healthcare Corporation, Round Lake, IL, USA;
³Pfizer, Inc., Groton, CT, USA;
⁴Bausch & Lomb, Rochester, NY, USA;
⁵Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; and
⁶United States Food and Drug Administration, Washington, DC, USA

↵*Corresponding Author: Diane Paskiet, West Pharmaceutical Services, 530 Herman O. West Drive, Exton PA 19341-1147. diane.paskiet{at}westpharma.com

View Full Text

Cited By...

53 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Non-targeted analysis (NTA) and suspect screening analysis (SSA): a review of examining the chemical exposome

Katherine E. Manz, Anna Feerick, Joseph M. Braun, Yong-Lai Feng, Amber Hall, Jeremy Koelmel, Carlos Manzano, Seth R. Newton, Kurt D. Pennell, Benjamin J. Place, Krystal J. Godri Pollitt, Carsten Prasse, Joshua A. Young

Journal of Exposure Science & Environmental Epidemiology 2023 33 4
Physico-chemical ageing of ethylene–norbornene copolymers: a review

Wowro Sonia Rosine Lago, Caroline Aymes-Chodur, Ange Privat Ahoussou, Najet Yagoubi

Journal of Materials Science 2017 52 11
Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics – Current challenges and approaches

Thomas H. Broschard, Susanne Glowienke, Uma S. Bruen, Lee M. Nagao, Andrew Teasdale, Cheryl L.M. Stults, Kim L. Li, Laurie A. Iciek, Greg Erexson, Elizabeth A. Martin, Douglas J. Ball

Regulatory Toxicology and Pharmacology 2016 81
Using default methodologies to derive an acceptable daily exposure (ADE)

Ellen C. Faria, Joel P. Bercu, David G. Dolan, Eric J. Morinello, Alison M. Pecquet, Christopher Seaman, Claudia Sehner, Patricia A. Weideman

Regulatory Toxicology and Pharmacology 2016 79
Large-Scale Assessment of Extractables and Leachables in Single-Use Bags for Biomanufacturing

Noemí Dorival-García, Sara Carillo, Christine Ta, Dominic Roberts, Kate Comstock, Simon Lofthouse, Elena Ciceri, Kyle D’Silva, Gerald Kierans, Christian Kaisermayer, Anna Lindeberg, Jonathan Bones

Analytical Chemistry 2018 90 15
Analytical challenges and recent advances in the identification and quantitation of extractables and leachables in pharmaceutical and medical products

Gagandeep Singh, Dujuan Lu, Chongming Liu, Danny Hower

TrAC Trends in Analytical Chemistry 2021 141
Identification, analysis and safety assessment of leachables and extractables

Dennis Jenke

TrAC Trends in Analytical Chemistry 2018 101
Identification of leachable impurities in an ophthalmic drug product originating from a polymer additive Irganox 1010 using mass spectroscopy

Gagandeep Singh, Ramarao Gollapalli, Alejandro Blinder, Milan Patel

Journal of Pharmaceutical and Biomedical Analysis 2018 152
The role of mass spectrometry and related techniques in the analysis of extractable and leachable chemicals

Vincent P. Sica, Kady L. Krivos, Douglas E. Kiehl, Christopher J. Pulliam, Ian D. Henry, Timothy R. Baker

Mass Spectrometry Reviews 2020 39 1-2
Evaluation of Extractables in Processed and Unprocessed Polymer Materials Used for Pharmaceutical Applications

Cheryl L. M. Stults, Jennifer M. Ansell, Arthur J. Shaw, Lee M. Nagao

AAPS PharmSciTech 2015 16 1
Solid phase extraction in tandem with GC/MS for the determination of semi-volatile organic substances extracted from pharmaceutical packaging/delivery systems via aqueous solvent systems

Steven A. Zdravkovic

Journal of Pharmaceutical and Biomedical Analysis 2015 112
Identification of additives in polymers from single-use bioprocessing bags by accelerated solvent extraction and ultra-high performance liquid chromatography coupled with high-resolution mass spectrometry

Noemí Dorival–García, Fabrizio Galbiati, Ralf Kruell, Roman Kovasy, Simon O. Dunne, Kyle D'Silva, Jonathan Bones

Talanta 2020 219
Identification of leachables observed in the size exclusion chromatograms of a low concentration product stored in prefilled syringes

Joseph J. Valente, Michael B. Peddicord, Frank A. Rinaldi, Kathleen A. Kelly, Mark S. Bolgar

Journal of Pharmaceutical and Biomedical Analysis 2017 139
Using extractables data from single-use components for extrapolation to process equipment-related leachables: The toolbox and justifications

Armin Hauk, Ina Pahl, Samuel Dorey, Roberto Menzel

European Journal of Pharmaceutical Sciences 2021 163
Development of an HPLC/UV method for the evaluation of extractables and leachables in plastic: Application to a plastic-packaged calcium gluconate glucoheptonate solution

Pauline Legrand, Anne Desdion, Gaétan Boccadifuoco, Amélie Dufaÿ Wojcicki, Alan Worsley, Vincent Boudy, Sophie Goulay Dufay

Journal of Pharmaceutical and Biomedical Analysis 2018 155
Expanding Bedside Filtration—A Powerful Tool to Protect Patients From Protein Aggregates

Benjamin Patrick Werner, Gerhard Winter

Journal of Pharmaceutical Sciences 2018 107 11
Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC-UV stability-indicating method

Frédéric Feutry, Nicolas Simon, Stéphanie Genay, Damien Lannoy, Christine Barthélémy, Bertrand Décaudin, Pierre Labalette, Pascal Odou

Drug Development and Industrial Pharmacy 2016 42 1
A case study demonstrating the migration of diethyl phthalate from an ancillary component to the drug product

Gagandeep Singh, Ramarao Gollapalli, Alejandro Blinder, Felix Gallo, Milan Patel

Journal of Pharmaceutical and Biomedical Analysis 2019 164
Considerations for the Terminal Sterilization of Oligonucleotide Drug Products

Daniel Paul DeCollibus, Justin Searcy, Anna Tivesten, Nadim Akhtar, Christian Lindenberg, Nounja Abarrou, Sujana Pradhan, Maggie Fiandaca, Jenny Franklin, Geetha Govindan, Hung-Yi Liu, David Royle, Patrick Lim Soo, Kirsten Storch

Nucleic Acid Therapeutics 2023 33 3
Framework for sensitization assessment of extractables and leachables in pharmaceuticals

Patricia Parris, Geraldine Whelan, Anders Burild, Jessica Whritenour, Uma Bruen, Joel Bercu, Courtney Callis, Jessica Graham, Esther Johann, Troy Griffin, Martin Kohan, Elizabeth A. Martin, Melisa Masuda-Herrera, Brad Stanard, Eric Tien, Maureen Cruz, Lee Nagao

Critical Reviews in Toxicology 2022 52 2
Identification of an Adduct Impurity of an Active Pharmaceutical Ingredient and a Leachable in an Ophthalmic Drug Product Using LC-QTOF

Ramarao Gollapalli, Gagandeep Singh, Alejandro Blinder, Jeremiah Brittin, Arijit Sengupta, Bikash Mondal, Milan Patel, Biswajit Pati, James Lee, Amit Ghode, Mahesh Kote

Journal of Pharmaceutical Sciences 2019 108 10
Prefilled dual chamber devices (DCDs) – Promising high-quality and convenient drug delivery system

Rahul G. Ingle, Wei-Jie Fang

International Journal of Pharmaceutics 2021 597
A Minireview on Brain Models Simulating Geometrical, Physical, and Biochemical Properties of the Human Brain

Yassine Bouattour, Valérie Sautou, Rodayna Hmede, Youssef El Ouadhi, Dimitri Gouot, Philip Chennell, Yuri Lapusta, Frédéric Chapelle, Jean-Jacques Lemaire

Frontiers in Bioengineering and Biotechnology 2022 10
Evaluation of Two Cosolvency Models to Predict Solute Partitioning between Polymers (LDPE) and Water - Ethanol Simulating Solvent Mixtures

Thomas Egert, Horst-Christian Langowski

Pharmaceutical Research 2022 39 4
Development of a generic approach for monitoring leachable compounds in hospital pharmacy-prepared prefilled plastic packaging by ultrahigh-performance liquid chromatography coupled to high-resolution mass spectrometry with postcolumn infusion

William Bello, Julian Pezzatti, Markoulina Berger-Gryllaki, Serge Rudaz, Farshid Sadeghipour

Journal of Pharmaceutical and Biomedical Analysis 2023 236
Identification of an Oxidizing Leachable from a Clinical Syringe Rubber Stopper

Ariane Schröter, Sonja Peter, Hanns-Christian Mahler, Andreas Zerr, Ombeline Danton, Pascal Chalus, Atanas V. Koulov, Jörg Huwyler, Michael Jahn

Journal of Pharmaceutical Sciences 2021 110 10
Permitted Daily Exposure Values: Application Considerations in Toxicological Risk Assessments

Douglas J. Ball, William P. Beierschmitt

International Journal of Toxicology 2020 39 6
Single‐Use Technology in Biopharmaceutical Manufacture

Alicja Sobańtka, Christian Weiner

2019
Detection and quantification of leached ethylene glycol in biopharmaceuticals by RP-UHPLC

Víctor Pérez Medina Martínez, Carlos Eduardo Espinosa de la Garza, Antonio Germán Hernández-García, Néstor O. Pérez

Analytical and Bioanalytical Chemistry 2020 412 8
Harmonisation of read-across methodology for drug substance extractables and leachables (E&Ls)

Melisa Masuda-Herrera, Hannah T. Rosen, Anders Burild, Thomas Broschard, Tyler Bell, Jessica Graham, Troy Griffin, Jedd Hillegass, Penny Leavitt, Brian Huta, Patricia Parris, Uma Bruen, Maureen Cruz, Joel Bercu

Regulatory Toxicology and Pharmacology 2023 145
In vitro toxicity of infusion sets depends on their composition, storage time and storage conditions

Luba Kozlovskaya, Hen Popilski, Pavel Gorenbein, David Stepensky

International Journal of Pharmaceutics 2015 489 1-2
Development of a generic sample preparation method using dispersive liquid–liquid microextraction for the monitoring of leachable compounds in hospital pharmacy-prepared prefilled drug products

William Bello, Julian Pezzatti, Serge Rudaz, Farshid Sadeghipour

Analytical Methods 2024 16 11
Development of the risk-based, phased-in approach for the international harmonization of the regulation of container closure systems for drugs in Taiwan

Lin-Chau Chang, Jaw-Jou Kang, Churn-Shiouh Gau

Regulatory Toxicology and Pharmacology 2016 77
Semiquantitative sensitization safety assessment of extractable and leachables associated with parenteral pharmaceutical products

Frank Liu, Richard W. Hutchinson

Regulatory Toxicology and Pharmacology 2023 138
Study of leachable compounds in hospital pharmacy-compounded prefilled syringes, infusion bags and vials

William Bello, Julian Pezzatti, Serge Rudaz, Farshid Sadeghipour

Journal of Pharmaceutical Sciences 2024 113 11
Specification of Drug Substances and Products

Kurt L. Moyer, James R. Scull, Michael Ruberto

2020
An in silico workflow for assessing the sensitisation potential of extractables and leachables

Martyn L. Chilton, Mukesh Patel, Antonio Anax F. de Oliveira

Computational Toxicology 2023 27
Challenges in setting permitted daily exposure limits for pharmaceuticals: A review

Varun Ahuja, Mohan Krishnappa

International Journal of Risk & Safety in Medicine 2022 33 1
Determination of Response Factors for Analytes Detected during Migration Studies, Strategy and Internal Standard Selection for Risk Minimization

Nikolaos Kritikos, Anna Bletsou, Christina Konstantinou, Antonios-Dionysios Neofotistos, Constantinos Kousoulos, Yannis Dotsikas

Molecules 2023 28 15
A critical opinion-based review of hospital pharmacy compounding with respect to the risk of leachable substances due to the off-label use of plastic primary packaging

William Bello, Julian Pezzatti, Camille Stampfli, Laurent Carrez, Serge Rudaz, Farshid Sadeghipour

Therapeutic Advances in Drug Safety 2025 16
Considerations and derivations of permitted daily exposure limits for impurities from intravitreal pharmaceutical products

Yi Yu Rice, David G. Dolan, Suren B. Bandara, Ryan E. Morgan, Michael Garry, Joyce Tsuji

Regulatory Toxicology and Pharmacology 2025 155
Derivation of permitted daily exposure value for trifluoroacetic acid as an impurity in pharmaceutical products

Hisakazu Sanada, Tsukasa Kikuno, Kimiyoshi Kitamura, Kiyohiro Hashimoto, Masayuki Mishima

Fundamental Toxicological Sciences 2023 10 7
Development and application of a protocol for extractables profiling from central venous catheters in neonates

Yoann Le Basle, Jérémy Pinguet, Yassine Bouattour, Philip Chennell, Valérie Sautou, Bénédicte Mailhot-Jensen

Journal of Pharmaceutical and Biomedical Analysis 2024 246
Encyclopedia of Toxicology

Shayne C. Gad

2024
Extractables and Leachables

2022
Extractables and Leachables

2022
From extractables to exposure data: Sensitivity analysis of extrapolation algorithms with focus on USP 〈665〉

Armin Hauk, Alexander Wildschütz, Ina Pahl, Daniel Canton, Roberto Menzel

European Journal of Pharmaceutical Sciences 2025 207
Optimization of Stability-Indicating HPLC Method for Analyzing Process Related Impurities of Penfluridol and Structural Elucidation of Stress Degradation Products by LCMS/MSucidation of Stress Degradation Products by LCMS/MS

Beram Adilakshmi, V. K. Rohini, T. Eswarlal, Ch. Lakshmi Prasanna, Venkateswara Rao Anna

Toxicology International 2023
QUANTIFICATION OF HYDRAZINE HYDRATE IN IMATINIB MESYLATE AT GENOTOXIC LEVEL BY CHROMATOGRAPHIC METHOD

C. Sojitra, S Agarwal, C. Dholakia, P. Sudhakar, K. K Singh

INDIAN DRUGS 2019 56 12
Safety assessment of drug impurities for patient safety: A comprehensive review

Frank Liu

Regulatory Toxicology and Pharmacology 2024 153
Scientifically Supported Best Practices in Leachable Screening Studies for Pharmaceutical and Parenteral Drug Products

Arvind Singh Gusain, Subhash Chandra, Isaac Moura Araújo, João Paulo Martins de Lima, Henrique Douglas Melo Coutinho

Future Pharmacology 2025 5 2
Study of extractables and leachables of non‐polyvinyl chloride soft infusion bags from different batches by analytical assessment threshold screening

Zheng Lu, Xuechun Sun, Augustine Atta Debraha, Zhenxia Du

Packaging Technology and Science 2024 37 2
Study of polymer component migrated in medicinal product from transportation packaging component: A systematic assessment beyond regulatory expectations

Sandeep Zokande, Kavita Inamdar, Amit Gosar, Amit Kale

Journal of Pharmaceutical Sciences 2024 113 12

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 67, Issue 5

September/October 2013

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP)

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 2 + 13 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP)

Diane Paskiet, Dennis Jenke, Douglas Ball, Christopher Houston, Daniel L. Norwood, Ingrid Markovic

PDA Journal of Pharmaceutical Science and Technology Sep 2013, 67 (5) 430-447; DOI: 10.5731/pdajpst.2013.00936

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP)

Diane Paskiet, Dennis Jenke, Douglas Ball, Christopher Houston, Daniel L. Norwood, Ingrid Markovic

PDA Journal of Pharmaceutical Science and Technology Sep 2013, 67 (5) 430-447; DOI: 10.5731/pdajpst.2013.00936

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Development of Duration-Based Non-Mutagenic Thresholds of Toxicological Concern (TTCs) Relevant to Parenteral Extractables and Leachables (E&Ls)
Principles for Management of Extractables and Leachables in Ophthalmic Drug Products
Integration of Regulatory Guidelines into Protein Drug Product Development
Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products

Google Scholar

PQRI Special Section

Extractables Characterization for Five Materials of Construction Representative of Packaging Systems Used for Parenteral and Ophthalmic Drug Products
Perspectives on the PQRI Extractables and Leachables “Safety Thresholds and Best Practices” Recommendations for Inhalation Drug Products

Show more PQRI Special Section

Review

A Risk Assessment and Risk-Based Approach Review of Pre-Use/Post-Sterilization Integrity Testing (PUPSIT)
Recommendations for Artificial Intelligence Application in Continued Process Verification: A Journey Toward the Challenges and Benefits of AI in the Biopharmaceutical Industry
A Review of Artificial Intelligence and Machine Learning in Product Life Cycle Management

Show more Review

Keywords

Extractables
Leachables
Safety assessment
Safety qualification thresholds
parenteral and ophthalmic drug products
Best practice recommendations
Biologic concerns
PQRI
Parenteral packaging
Ophthalmic containers

Main menu

User menu

Search

The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP)

Article Information

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

PQRI Special Section

Review

Similar Articles

Keywords

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.